CYTOKINETICS, INCORPORATED (CYTK) Capital expenditures 2016–2025
CYTOKINETICS, INCORPORATED (CYTK) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$24.8MFY2025 · since FY2016: $1.6M → $24.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24.8M | +535.1% |
| FY2024 | $3.9M | +175.8% |
| FY2023 | $1.4M | -87.5% |
| FY2022 | $11.3M | -76.8% |
| FY2021 | $48.9M | +342.2% |
| FY2020 | $11.1M | +322.0% |
| FY2019 | $2.6M | +194.6% |
| FY2018 | $889,000 | -69.1% |
| FY2017 | $2.9M | +80.3% |
| FY2016 | $1.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice